Stockscreener 앱 받기
14.39
3.95%
-0.535
Biodesix Inc 주식(BDSX)의 최신 뉴스
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - Zacks Investment Research
Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions - Insider Monkey
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Biodesix (NASDAQ: BDSX) registers 375,000 shares for Perceptive resale - Stock Titan
Biodesix meets investors in Minneapolis, Chicago and Dana Point - Stock Titan
Biodesix to Participate in Upcoming Investor Conferences - Caledonian Record
Biodesix shareholders elect directors and approve executive compensation By Investing.com - Investing.com Australia
Biodesix shareholders elect directors and approve executive compensation - Investing.com
Biodesix Shareholders Approve Directors and Governance Measures - TipRanks
Biodesix (NASDAQ: BDSX) holders back directors, pay and KPMG auditor - Stock Titan
Perceptive entities disclose 4.6% holding in Biodesix (NASDAQ: BDSX) - Stock Titan
Biodesix BDSX Q2 2025 Earnings Call Transcript - AOL.com
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy - The Manila Times
Blood test for lung nodules gets real-world spotlight at ATS 2026 - Stock Titan
Biodesix to present new real-world data on Nodify Lung testing at ATS 2026, highlighting clinical and economic benefits. - Pluang
Does Biodesix (BDSX) have the potential to rally 103.33% as Wall Street analysts expect? - MSN
Biodesix (NASDAQ: BDSX) holder Soleus reports 416,599 shares (4.1%) - Stock Titan
Biodesix Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Q3 2025 Biodesix Inc Earnings Call Transcript - GuruFocus
Number of shareholders of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect? - Yahoo Finance
Biodesix Earnings Call Signals Strong Growth Momentum - The Globe and Mail
Biodesix Faces Mounting Reimbursement and Enforcement Risks as Evolving Payer Policies Threaten Revenue Stability - TipRanks
TD Cowen Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MSN Money - MSN
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Biodesix touts ‘clear path toward profitability’ - BizWest
William Blair Maintains Biodesix(BDSX.US) With Buy Rating - Moomoo
Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $40 - Moomoo
CCORF Maintains Biodesix(BDSX.US) With Buy Rating, Raises Target Price to $22 - Moomoo
Biodesix Inc. 10-Q Q1 2026: Financial Statements, Risk Factors, and Management Analysis - Minichart
Biodesix stock price target raised to $22 by Canaccord on revenue growth - Investing.com
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript - Insider Monkey
Biodesix (BDSX) Q1 2026 Earnings Transcript - AOL.com
Biodesix, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Biodesix Q1 Earnings Call Highlights - MarketBeat
BDSX Financials: Income Statement, Balance Sheet & Cash Flow | BIODESIX INC - Stock Titan
BDSX: Q1 revenue up 42% year-over-year, with raised 2026 guidance and margin expansion - TradingView
Biodesix Q1 2026 Earnings Call: Complete Transcript - Benzinga
Earnings call transcript: Biodesix Q1 2026 shows revenue growth, stock steady - Investing.com
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Biodesix Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance - ChartMill
Biodesix (NASDAQ:BDSX) Announces Earnings Results, Beats Estimates By $0.32 EPS - MarketBeat
Q1 2026 Biodesix Inc Earnings Call Transcript - GuruFocus
0.23%
0.65%
자본화:
|
볼륨(24시간):